Collision course — Prices would need to be dramatically slashed to avoid increasing the national deficit. Enlarge / Packaging for Wegovy, manufactured by Novo Nordisk, is seen in this illustration photo. With the debut of remarkably effective weight-loss drugs, America's high obesity rate and its uniquely astronomical prescription drug pricing appear to be set on a catastrophic collision course—one that threatens to "bankrupt our entire health care system," according to a new Senate report th...